Department of Biological Sciences, City University of New York, Hunter College, New York, NY 10065, USA.
J Immunol. 2013 Jul 1;191(1):472-9. doi: 10.4049/jimmunol.1300521. Epub 2013 May 29.
Locus control regions (LCRs) are cis-acting gene regulatory elements with the unique, integration site-independent ability to transfer the characteristics of their locus-of-origin's gene expression pattern to a linked transgene in mice. LCR activities have been discovered in numerous T cell lineage-expressed gene loci. These elements can be adapted to the design of stem cell gene therapy vectors that direct robust therapeutic gene expression to the T cell progeny of engineered stem cells. Currently, transgenic mice provide the only experimental approach that wholly supports all the critical aspects of LCR activity. In this study, we report the manifestation of all key features of mouse TCR-α gene LCR function in T cells derived in vitro from mouse embryonic stem cells. High-level, copy number-related TCR-α LCR-linked reporter gene expression levels are cell type restricted in this system, and upregulated during the expected stage transition of T cell development. We also report that de novo introduction of TCR-α LCR-linked transgenes into existing T cell lines yields incomplete LCR activity. These data indicate that establishing full TCR-α LCR activity requires critical molecular events occurring prior to final T lineage determination. This study also validates a novel, tractable, and more rapid approach for the study of LCR activity in T cells, and its translation to therapeutic genetic engineering.
基因座控制区(LCRs)是顺式作用的基因调控元件,具有独特的、整合位点非依赖性的能力,可将其起源基因表达模式的特征转移到小鼠中的连接转基因上。已经在许多 T 细胞谱系表达基因座中发现了 LCR 活性。这些元件可以被适用于设计干细胞基因治疗载体,以将强大的治疗性基因表达导向工程化干细胞的 T 细胞后代。目前,转基因小鼠提供了唯一完全支持 LCR 活性所有关键方面的实验方法。在这项研究中,我们报告了源自小鼠胚胎干细胞的体外 T 细胞中鼠 TCR-α 基因 LCR 功能的所有关键特征的表现。在该系统中,高水平、与拷贝数相关的 TCR-α LCR 连接报告基因表达水平受到细胞类型的限制,并在 T 细胞发育的预期阶段过渡中上调。我们还报告说,TCR-α LCR 连接的转基因在现有 T 细胞系中的从头引入产生不完全的 LCR 活性。这些数据表明,建立完整的 TCR-α LCR 活性需要在最终 T 谱系确定之前发生关键的分子事件。这项研究还验证了一种新颖、易于处理和更快的方法,用于研究 T 细胞中的 LCR 活性及其向治疗性基因工程的转化。